Kirko Kirkov
CIK: 0001946043
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ELTP
ELITE PHARMACEUTICALS INC /NV/
Officer
Discretionary Trading P&L
Holdings
About Kirkov Kirko
Kirkov Kirko (SEC CIK 0001946043) files insider reports with the SEC as Chief Commercial Officer of ELITE PHARMACEUTICALS INC /NV/ (ELTP).
Signal8 holds 1 ownership filing by Kirkov Kirko, a Form 4, filed on Jul 25, 2025. Those filings report 1 transaction, the latest on Jul 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kirkov Kirko's filings is in NORTHVALE, NJ.
Recent filings by Kirkov Kirko
- Jul 10, 2025: Open-market purchase of ELTP shares (Form 4, code P).
Other insiders filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP)
- Dash Barry H, Director
- Plassche Douglas, EVP Operations
- ELITE PHARMACEUTICALS INC /NV/, EVP Operations